GTBiopharma
0 followers
GT Biopharma is generating novel immuno-oncology biopharmaceutical drugs targeting cancers such as acute lymphocytic leukemia, non-Hodgkin's lymphoma, acute myeloid leukemia, and multiple solid tumors by leveraging their proprietary NK cell engager (TriKE™) platform technology.
Org chart
Michael Breen
Executive Chairman & Interim CEO
Michael Breen
Collapse
Manu Ohri
CFO
Gavin Choy
Chief Clinical Development Officer
Jeffrey S. Miller
Consulting CSO
Stacy Herb
SVP, Portfolio Management
